Osteoarthritis (OA) is the most common disease of joints and currently lacks treatment options that modify structural pathology [22, 23]. It is usually defined as the result of an imbalance in the degradation and synthesis of the normal coupling of chondrocytes, cell matrix, and subchondral bone under the influence of mechanical and biological factors [23, 24]. It is now generally accepted that the chondrocytes are the target of these abnormal biomechanical factors, and that biochemical and genetic factors also contribute to alterations in the normal functional activities of these cells [25]. Clinically, some researchers can judge the progress of osteoarthritis patients by the degradation of cartilage tissue proteoglycan and collagen fibers [26, 27]. Several genes have also been found to play important roles in the development of chondrogenesis in osteoarthritis and can serve as markers for the development of osteoarthritis. Zhu and his partners found lncRNA FAS-AS1 could promote the degradation of extracellular matrix of cartilage in osteoarthritis by increased the expressions of MMP1 and MMP13 and decreased the expression of COL2A1 in chondrocytes [27]. These genes could also be used for predicting the internal state of chondrocytes in OA pathogenesis. However, due to the complexity of chondrocyte differentiation in osteoarthritis and lack of specific biomarker to characterize chondrocyte differentiation in osteoarthritis, the differentiation and cell subtype of chondrocytes in osteoarthritis is not known. Here, we investigated OA chondrocytes at different stages by using scRNA-seq analysis. We found 3 populations of chondrocytes (HTCs, HomCs and FCs), new markers of chondrocyte populations and signaling pathways involved in OA pathogenesis based on scRNA-seq analysis. We also found the hub genes which may play important roles in the 3 populations respectively. There results may contribute to the early diagnosis and therapeutic treatment of human OA.
In this study, we found 3 cell populations (HTCs, HomCs and FCs) in chondrocytes of 3 OAs. Hypertrophic chondrocytes are divided into prohypertrophy and hypertrophy [28]. In recent years, the research on hypertrophic chondrocytes has become a hot topic in the research of osteoarthritis. Many hypertrophic chondrocytes were found in the degenerative articular cartilage [29]. These chondrocytes have different types of collagen which have different roles in the development of osteoarthritis. It is important to study the specific role of hypertrophic chondrocytes in osteoarthritis and the genes that regulate chondrocytes. In our study, we also found HTCs were existed in chondrocytes of OAs. The GO analysis of HTCs concentrated on oxidative stress, epithelial cell proliferation and growth factor. Some researchers found SIN-1 could induce oxidative stress leads to necrosis in hypertrophic chondrocytes [30, 31]. For cell proliferation and growth factor, some growth factor such as COL10A1 and ALP were high expression in hypertrophic chondrocytes and promote the proliferation of HTCs [32, 33]. Therefore, the candidate marker genes of HTCs may have close relationships with proliferation and differentiation of HTCs in OAs. The expression analysis of top 10 candidate marker genes in different types of chondrocyte also showed TNFAIP6, GAS1, SLC7A2 and TNC were high expression in HTCs. TNFAIP6, GAS1 and TNC have been found associated with the biological function of chondrocyte or cartilage by other researchers [34–36]. The change in expression level of these genes in HTCs of OAs can be used to judge the development status of OA.
Compared with HTCs, there are few reports on the role of HomCs and FCs in osteoarthritis. FCs are new cell types that have been discovered to differentiate from chondrocytes in recent years. FCs, that was mainly found in the late stages of OA and possessed a high ratio of genes related to unfavorable OA outcomes and a capacity for vascularization [21, 37]. The GO and KEGG analysis showed FCs have close relationship with collagen formation. The macromolecular framework of articular cartilage consists of collagens (predominantly type II collagen), proteoglycans, and non-collagenous proteins [3, 38]. Of which, collagen is the matrix that provides the cartilage with its tensile stiffness and strength. It is possible for researchers to find new treatments of OA by regulating the collagen formation and proliferation of fibrocartilage chondrocytes which could secret collagen. We also found 6 candidate marker genes (S100A4, COL1A2, TMSB4X, THY1, COL14A1 and IFI27) were high expression in FCs. These genes may be used as biomarkers for distinguish FCs from other chondrocytes. HomCs can help regulate the homeostatic balance of chondrocyte metabolic activity in response to environmental signals. This type of chondrocyte may play an important role in maintaining rhythmic behaviors and daily cycles of metabolism during OA cartilage degeneration [39, 40]. The functions and pathways analysis of HomCs in our results showed regulated cell cycle, development, RNA metabolism and biosynthesis. We also found all top 10 candidate marker genes of HomCs were high expression among among resCs, proCs, HTCs. These results imply these candidate marker genes of HomCs might regulate the circadian clock system of chondrocyte in OAs.
Three hub genes were also found among these candidate genes in HTCs, HomCs and FCs respectively. CD44 is the membrane receptor for hyaluronan. CD44 is the primary receptor of retention and anchoring of proteoglycan aggregates to the chondrocyte plasma membrane [41, 42]. This receptor also paly important roles in cartilage such as maintains cartilage homeostasis and affects both chondrocyte survival pathways as well as apoptotic pathways [43, 44]. In this study we regarded CD44 as the hub gene of HTCs and found this receptor was high expression in HTCs. These results show CD44 is a biomarker of HTCs in OA and this receptor exerts more influence on HTCs than other types of chondrocyte in OA. JUN is also known as AP-1. The abnormal expression of JUN in chondrocyte can affect the differentiation of chondrocyte in growth cartilage. Motomura and his partners found specific inhibition of c-Fos/AP-1 could regulate differentiation of chondrocyte in OA which effectively prevented cartilage destruction and osteophyte formation [45]. Some researchers also found the suppression of c-Fos/AP-1 expression could regulate activity of OA chondrocyte under pathological conditions [46]. In our study, we found JUN which was the hub gene of HomCs was high expression among different types of chondrocyte except for FCs. The function of HomCs mainly focus on maintain rhythmic behaviors and daily cycles of metabolism during OA cartilage degeneration. We speculate JUN may inhibits the differentiation of chondrocyte by affecting cell cycle of chondrocyte. Fibronectin1 is a glycoprotein present in a soluble dimeric form in plasma, and in a dimeric or multimeric form at the cell surface and in extracellular matrix. Some researchers found FN1 could increase chondrocyte cell death [47]. The high expression of FNI in fibrocartilage chondrocytes in our study implied this gene could be used for testing the growth of fibrocartilage.